Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Zubsolv
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zubsolv 1.4mg/0.36mg sublingual tablets
0410030B0BCAAAG
|
Zubsolv | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 3 |
|
Zubsolv 11.4mg/2.9mg sublingual tablets
0410030B0BCADAJ
|
Zubsolv | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Zubsolv 2.9mg/0.71mg sublingual tablets
0410030B0BCABAH
|
Zubsolv | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Zubsolv 5.7mg/1.4mg sublingual tablets
0410030B0BCACAI
|
Zubsolv | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Zubsolv 8.6mg/2.1mg sublingual tablets
0410030B0BCABAF
|
Zubsolv | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.